Acadia Healthcare Co: Q3 Earnings Insights

Shares of Acadia Healthcare Co ACHC rose 3.52% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share increased 30.77% over the past year to $0.68, which beat the estimate of $0.54.

Revenue of $833,304,000 higher by 7.21% year over year, which beat the estimate of $800,240,000.

Outlook

Acadia Sees Q4 Adj. EPS $0.68-$0.72 vs $0.56 Estimate, Sales $810M-$835M vs $815M Est., Adj. EBITDA $160M-$165M

Recent Stock Performance

52-week high: $35.30

52-week low: $11.09

Price action over last quarter: down 2.94%

Company Description

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.